Medivault Life is building the premium cold storage category for injectable medications and luxury skincare — two massive markets with an identical, unsolved problem.
Two converging markets. One unsolved infrastructure problem. No premium brand has claimed this space — until now.
Millions of people are now managing injectable protocols at home that would have required clinical oversight a decade ago. GLP-1 medications. Peptide therapies. TRT. IVF. The compounds are sophisticated. The storage is not.
At the same time, the premium skincare market has moved to biological actives — vitamin C, retinol, peptide complexes — that degrade rapidly without cold storage. The investment is real. The infrastructure doesn't exist.
Medivault Life is the first brand to address both markets with premium, purpose-built cold storage systems.
Both products share core technology and manufacturing. Different audiences, different aesthetics, one platform.
Mark Jansen didn't come to Medivault Life through a business plan. He came through a lifestyle. Coming from a fitness and performance background, he watched firsthand as health evolved from workouts and nutrition into precision-based, protocol-driven routines.
He saw the gap between the sophistication of the compounds people were using and the complete absence of any infrastructure to support them. And he couldn't unsee it.
Whether you're an investor, press, or potential partner — we want to hear from you.